Related Experiment Videos
GLUT12: a second insulin-responsive glucose transporters as an emerging target for type 2 diabetes
Takashi Matsuzaka1, Hitoshi Shimano1
1Department of Internal Medicine (Endocrinology and Metabolism), Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan.
Journal of Diabetes Investigation
|May 21, 2014
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Obesity Disrupts CtBP2-Mediated Maintenance of Transcriptional Equilibrium in Hypothalamic Feeding Circuitry.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Non-Autoimmune Hyperthyroidism Associated With a Novel Germline Mutation (D633N) in the TSH Receptor.
Case reports in endocrinology·2026
Hepatic steatosis risk in nonobese Chinese adults with type 1 diabetes.
Journal of diabetes investigation·2026
Type 1 diabetes in the era of obesity: Pathophysiology and therapeutic implications.
Journal of diabetes investigation·2026
WTAP-mediated m6A RNA methylation promotes diabetic foot ulcer healing under negative pressure wound therapy.
Journal of diabetes investigation·2026
Influence of age on the development of stress hyperglycemia during first-onset ST-elevation myocardial infarction.
Journal of diabetes investigation·2026
Use of glucagon-like peptide-1 receptor agonists is associated with inadequate bowel preparation for colonoscopy in patients with diabetes.
Journal of diabetes investigation·2026
Deficiency of GLUT1 in macrophages reprograms tumor-associated macrophages to normalize tumor vasculature and retards the progression of tumors.
International journal of biological sciences·2026
From static risk to dynamic disease monitoring: the role of MRD and immune profiling in multiple myeloma.
Frontiers in immunology·2026
Doravirine and islatravir for HIV-1 treatment: A systematic review and meta-analysis with GRADE assessment.
Therapeutic advances in infectious disease·2026
Advancement in Inflammation-responsive Drug Delivery System for Chronic Inflammation.
Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026